The next generation of obesity and diabetes trials are being run out of Australia. Sponsors who once defaulted to the US or Europe are increasingly choosing us. The question...
When biotechs and major pharma companies need to fast-track early drug trials, they’re increasingly skipping Boston and California and choosing Melbourne instead. They can begin enrolling patients within weeks,...
National science institutions, a radio telescope program, and a handful of biosecurity and medical research projects enjoyed a boost in Jim Chalmers’ fourth Budget, which lacked a significant response...
Grants worth $12 million have been awarded through the federally-funded BioTech incubator CUREator to 19 projects across Australia. In the second round of funding, announced on Wednesday, $6 million...
More than $35 million will go towards a Queensland vaccine manufacturing facility as part of the state budget next week. The funds will support the development of a translational...
The Victorian government has awarded $2 million to 12 mRNA projects through the state’s new Research Acceleration Fund. Launched by mRNA Victoria in April last year, the $25 million...
Half a decade of domestic growth in the clinical trials sector has failed to attract a greater share of global industry-sponsored trials to Australia, according to a new report...
It is no accident that the idea of Australia “punching above its weight” became a colloquial commonplace in the 1980s and 1990s. It was the time when Australian efforts...